Medicus Biosciences

Medicus Biosciences is a clinical-stage biotechnology company specializing in the development of advanced hydrogel-based drug delivery systems and surgical sealants. The company's proprietary platform utilizes a unique, biodegradable hydrogel technology that can be engineered to provide controlled release of therapeutics or serve as a highly effective tissue adhesive. Their lead programs focus on ophthalmology, specifically for the long-term delivery of anti-VEGF agents, and post-operative pain management. By providing sustained-release formulations, Medicus aims to reduce the frequency of injections and improve patient compliance in chronic conditions. The company is headquartered in San Jose, California, and continues to expand its pipeline through internal development and strategic collaborations.